<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02762422</url>
  </required_header>
  <id_info>
    <org_study_id>08-411</org_study_id>
    <secondary_id>1R01HL086932</secondary_id>
    <secondary_id>UL1TR000038</secondary_id>
    <nct_id>NCT02762422</nct_id>
  </id_info>
  <brief_title>Serial Phlebotomy in Voluntary Blood Donors</brief_title>
  <official_title>Serial Phlebotomy in Voluntary Blood Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Blood donation has been proposed to be associated with reduced risk of cardiovascular
      disease, but the effects of phlebotomy on vascular function in human subjects have not been
      well characterized. A prospective randomized double-blind study was undertaken to determine
      the effects of iron loss and red blood cell loss induced by serial phlebotomy on vascular
      endothelial function in the brachial artery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      84 Fe-replete, non-anemic subjects were randomly assigned to one of three experimental serial
      phlebotomy procedures designed to induce Fe loss or RBC loss. Brachial artery reactivity
      (BAR, %) in response to transient oxidative stress induced by oral methionine was measured
      with high-resolution duplex ultrasound imaging before and after study phlebotomy procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brachial artery reactivity response to oral methionine administration</measure>
    <time_frame>Before and 1 week after completion of assigned phlebotomy procedures</time_frame>
    <description>Measure by vascular ultrasound imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Iron deficiency anemia</measure>
    <time_frame>before each phlebotomy procedure, and at 1, 8, and 16 weeks after completion of assigned phlebotomy procedures</time_frame>
    <description>hemoglobin level measured by hemocue or complete blood count</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>Before and 1 week after completion of assigned phlebotomy procedures</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serum nitrotyrosine</measure>
    <time_frame>Before and 1 week after completion of assigned phlebotomy procedures</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Whole blood viscosity</measure>
    <time_frame>Before and 1 week after completion of assigned phlebotomy procedures</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Phlebotomy plus normal saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four serial phlebotomy procedures followed by infusion of normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phlebotomy plus intravenous iron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four serial phlebotomy procedures followed by infusion of intravenous iron sucrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Phlebotomy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Four serial sham phlebotomy procedures followed by infusion of normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phlebotomy</intervention_name>
    <description>Removal of 500 cc of blood via forearm vein</description>
    <arm_group_label>Phlebotomy plus normal saline</arm_group_label>
    <arm_group_label>Phlebotomy plus intravenous iron</arm_group_label>
    <arm_group_label>Sham Phlebotomy</arm_group_label>
    <other_name>Blood donation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hemoglobin levels &gt;13.5 g/dl for men, or &gt;12.5 g/dl for women

          -  serum ferritin 50-400 ng/ml

        Exclusion Criteria:

          -  known intolerance of phlebotomy procedures

          -  major trauma or surgical procedures in the last 2 years

          -  menstrual or other uterine bleeding in the last 2 years

          -  chronic oral anticoagulation or dual antiplatelet therapy

          -  chronic non-steroidal anti-inflammatory drug use

          -  known history of hemochromatosis or other disorder of hematopoiesis or Fe metabolism

          -  chronic oral Fe supplementation other than Fe-containing multivitamins

          -  history of active cancer in the past 2 years

          -  known history of chronic inflammatory disease

          -  uncontrolled hypertension

          -  electrocardiographic evidence of prior myocardial infarction

          -  diabetes mellitus

          -  fasting glucose &gt;100 mg/dL

          -  body mass index &gt;40 kg/m2

          -  any tobacco use in the past 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart Katz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2016</study_first_submitted>
  <study_first_submitted_qc>May 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>May 4, 2016</last_update_submitted>
  <last_update_submitted_qc>May 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York University School of Medicine</investigator_affiliation>
    <investigator_full_name>Stuart Katz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>endothelial function</keyword>
  <keyword>iron stores</keyword>
  <keyword>red blood cell</keyword>
  <keyword>blood donation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>PI will make de-identified dataset available upon request in accord with institutional data use agreement policy</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

